Plasma proteomic profiling in dogs with pheochromocytoma
Journal of Veterinary Internal Medicine · 2026
DOI: 10.1093/jvimsj/aalag212 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Veterinary Internal Medicine, 2026. Verfasst von Marit F van den Berg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CM Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms, Dog Diseases, Pheochromocytoma, Proteome. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Maria Naundorf van Gorkum foundation, Foundation Abri, Friends of VetMed.
Abstract (Originalsprache)
Background
Pheochromocytomas (PCCs) in dogs are challenging to diagnose. Plasma proteomics offers a minimally invasive approach to identify circulating biomarkers and disease-relevant pathways. Hypothesis/Objectives To compare the plasma proteome of dogs with PCC and controls to (1) identify differentially abundant proteins, (2) characterize altered pathways, and (3) nominate candidate circulating biomarkers and therapeutic targets. Animals Plasma from 10 client-owned PCC dogs and 10 healthy controls.
Methods
Multicenter, retrospective, observational, exploratory study using label-free liquid chromatography-mass spectrometry. Primary outcomes were the identification of differentially abundant proteins and characterization of altered pathways and protein functions.
Results
Principal component analysis demonstrated clear separation between PCC and control dogs. Of 261 reliably quantified proteins, 51 were differentially abundant (false discovery rate-adjusted P < .05). Of these, 33 had a log2 fold change of >1 or < −1, with 15 showing higher and 18 lower plasma abundance in PCC. Compared with controls, PCC dogs showed increased abundance of proteins linked to cell adhesion/migration and metastatic potential, hemostasis, and regulation of apoptotic signaling, alongside alterations in oxidative stress and metabolic processes. Several proteins with higher abundance, including CD44, peroxiredoxin-2, and peptidyl-prolyl cis-trans isomerase, emerged as promising candidates for therapeutic exploration. Conclusions and clinical importance Dogs with PCC exhibit a distinct circulating protein signature vs healthy controls, providing clues to PCC pathogenesis and nominating proteins as diagnostic biomarker candidates and potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CM Utrecht, The Netherlands.
- Division for Small Animal Internal Medicine, Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
- Department of Veterinary Medical Sciences, Faculty of Veterinary Medicine, University of Bologna, 40064 Ozzano dell'Emilia, Italy.
ORCID-Profile: Marit F van den Berg, Alexandro Rodríguez-Rojas, Pavlos G Doulidis, Luciano Pisoni, Iwan A Burgener, Sara Galac
Förderung
- Maria Naundorf van Gorkum foundation
- Foundation Abri
- Friends of VetMed
- FWF
Zitieren
APA
van den Berg, M. F., Rodríguez-Rojas, A., Doulidis, P. G., Pisoni, L., Burgener, I. A., & Galac, S. (2026). Plasma proteomic profiling in dogs with pheochromocytoma. Journal of Veterinary Internal Medicine. https://doi.org/10.1093/jvimsj/aalag212
Vancouver
van den Berg MF, Rodríguez-Rojas A, Doulidis PG, Pisoni L, Burgener IA, Galac S. Plasma proteomic profiling in dogs with pheochromocytoma. Journal of Veterinary Internal Medicine. 2026. doi:10.1093/jvimsj/aalag212
BibTeX
@article{vandenBerg2026,
author = {van den Berg, Marit F and Rodríguez-Rojas, Alexandro and Doulidis, Pavlos G and Pisoni, Luciano and Burgener, Iwan A and Galac, Sara},
title = {Plasma proteomic profiling in dogs with pheochromocytoma},
journal = {Journal of Veterinary Internal Medicine},
year = {2026},
doi = {10.1093/jvimsj/aalag212}
}
EUVIMED